Home/Filings/4/0001209191-19-018982
4//SEC Filing

Krasner Alan Seth 4

Accession 0001209191-19-018982

CIK 0001658247other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 6:42 PM ET

Size

5.5 KB

Accession

0001209191-19-018982

Insider Transaction Report

Form 4
Period: 2019-03-08
Krasner Alan Seth
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-03-08+56,25056,250 total
    Exercise: $25.19Exp: 2029-03-07Common Stock (56,250 underlying)
Footnotes (1)
  • [F1]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019.

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001435775

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:42 PM ET
Size
5.5 KB